Clinical trials: Acellular Dermal Matrix
- Condition Acellular Dermal Matrix
- Funder type Industry (pharma, biotech, devices)
- Age group Children (under 18)
Breast Cancer
A Retrospective Breast Reconstruction Study
To collect data on patients who have previously undergone breast reconstruction utilizing SimpliDerm and other HADMs.
- Trial name
- NCT04060134
- Testing
- SimpliDerm HADM, AlloDerm HADM, AlloMax HADM
- Where
- 5 sites in United States
- Volunteers
- 223 people
- Sponsor
- Elutia Inc.